Rahul R Aggarwal (Rahul Aggarwal)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 44

Top Topics

Radical Prostatectomy

Long Noncoding Rna

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Nature communications

Cancer immunology research

Cancer research communications

This page only lists publications with an associated author ORCID identifier.

Publications

Rahul R Aggarwal, Glenn Heller, David W Hillman, Han Xiao, Joel Picus, Mary-Ellen Taplin, Tanya Barauskas Dorff, Leonard J Appleman, Douglas Weckstein, Akash Patnaik, Alan H Bryce, Daniel Shevrin, James L Mohler, Daniel Anderson, Arpit Rao, Scott T Tagawa, Alan Tan, Susan Halabi, Katharine E Dooley, Patrick O'Brien, Ronald C Chen, Charles J Ryan, Scott E Eggener, Michael J Morris, null null
PRESTO: A Phase III, Open-Label Study of Intensification of Androgen Blockade in Patients With High-Risk Biochemically Relapsed Castration-Sensitive Prostate Cancer (AFT-19). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (10) (2024)
Shuang G Zhao, Matthew Bootsma, Stanley Zhou, Raunak Shrestha, Thaidy Moreno-Rodriguez, Arian Lundberg, Chu Pan, Christopher Arlidge, James R Hawley, Adam Foye, Alana S Weinstein, Martin Sjostrom, Meng Zhang, Haolong Li, Lisa N Chesner, Nicholas R Rydzewski, Kyle T Helzer, Yue Shi, null null, Molly Lynch, Scott M Dehm, Joshua M Lang, Joshi J Alumkal, Housheng Hansen He, Alexander W Wyatt, Rahul R Aggarwal, Wilbert Zwart, Eric J Small, David A Quigley, Mathieu Lupien, Felix Y Feng
Integrated analyses highlight interactions between the three-dimensional genome and DNA, RNA and epigenomic alterations in metastatic prostate cancer. Nature genetics (2024)
Rahul R Aggarwal, Glenn Heller, David W Hillman, Han Xiao, Joel Picus, Mary-Ellen Taplin, Tanya Barauskas Dorff, Leonard J Appleman, Douglas Weckstein, Akash Patnaik, Alan H Bryce, Daniel Shevrin, James L Mohler, Daniel Anderson, Arpit Rao, Scott T Tagawa, Alan Tan, Susan Halabi, Katharine E Dooley, Patrick O'Brien, Ronald C Chen, Charles J Ryan, Scott E Eggener, Michael J Morris, null null
PRESTO: A Phase III, Open-Label Study of Intensification of Androgen Blockade in Patients With High-Risk Biochemically Relapsed Castration-Sensitive Prostate Cancer (AFT-19). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (10) (2024)
Hewitt Chang, Jaqueline Marquez Garcia, Brandon K Chen, Daniel M Kim, Michael L Cheng, Eric V Liu, Hai Yang, Li Zhang, Meenal Sinha, Alexander Cheung, Serena S Kwek, Eric D Chow, Mark Bridge, Rahul R Aggarwal, Terence W Friedlander, Eric J Small, Mark S Anderson, Lawrence Fong
Immune modulation with RANKL blockade through denosumab treatment in patients with cancer. Cancer immunology research (2024)
Edward B Maldonado, W Kimryn Rathmell, Geoffrey I Shapiro, Naoko Takebe, Jordi Rodon Ahnert, Devalingam Mahalingam, Nikolaos A Trikalinos, Arash Rezazadeh Kalebasty, Mamta Parikh, Scott A Boerner, Celene Balido, Gregor Krings, Timothy F Burns, Emily K Bergsland, Pamela N Munster, Alan Ashworth, Patricia M LoRusso, Rahul R Aggarwal
A Phase II Trial of the WEE1 Inhibitor Adavosertib in SETD2-Altered Advanced Solid Tumor Malignancies (NCI 10170). Cancer research communications 4 (7) (2024)
Rahul R Aggarwal, Glenn Heller, David W Hillman, Han Xiao, Joel Picus, Mary-Ellen Taplin, Tanya Barauskas Dorff, Leonard J Appleman, Douglas Weckstein, Akash Patnaik, Alan H Bryce, Daniel Shevrin, James L Mohler, Daniel Anderson, Arpit Rao, Scott T Tagawa, Alan Tan, Susan Halabi, Katharine E Dooley, Patrick O'Brien, Ronald C Chen, Charles J Ryan, Scott E Eggener, Michael J Morris, null null
PRESTO: A Phase III, Open-Label Study of Intensification of Androgen Blockade in Patients With High-Risk Biochemically Relapsed Castration-Sensitive Prostate Cancer (AFT-19). Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Hewitt Chang, Jaqueline Marquez Garcia, Brandon K Chen, Daniel M Kim, Michael L Cheng, Eric V Liu, Hai Yang, Li Zhang, Meenal Sinha, Alexander Cheung, Serena S Kwek, Eric D Chow, Mark Bridge, Rahul R Aggarwal, Terence W Friedlander, Eric J Small, Mark S Anderson, Lawrence Fong
Immune Modulation with RANKL Blockade through Denosumab Treatment in Patients with Cancer. Cancer immunology research 12 (4) (2024)
Mark C Markowski, Mary-Ellen Taplin, Rahul R Aggarwal, Laura A Sena, Hao Wang, Hanfei Qi, Aliya Lalji, Victoria Sinibaldi, Michael A Carducci, Channing J Paller, Catherine H Marshall, Mario A Eisenberger, David E Sanin, Srinivasan Yegnasubramanian, Carolina Gomes-Alexandre, Busra Ozbek, Tracy Jones, Angelo M DeMarzo, Samuel R Denmeade, Emmanuel S Antonarakis
Bipolar androgen therapy plus nivolumab for patients with metastatic castration-resistant prostate cancer: the COMBAT phase II trial. Nature communications 15 (1) (2024)
David R Wise, Russell K Pachynski, Samuel R Denmeade, Rahul R Aggarwal, Jiehui Deng, Victor Adorno Febles, Arjun V Balar, Minas P Economides, Cynthia Loomis, Shanmugapriya Selvaraj, Michael Haas, Michael H Kagey, Walter Newman, Jason Baum, Andrea B Troxel, Sarah Griglun, Dayna Leis, Nina Yang, Viktoriya Aranchiy, Sabrina Machado, Erika Waalkes, Gabrielle Gargano, Nadia Soamchand, Amrutesh Puranik, Pratip Chattopadhyay, Ezeddin Fedal, Fang-Ming Deng, Qinghu Ren, Luis Chiriboga, Jonathan Melamed, Cynthia A Sirard, Kwok-Kin Wong
A Phase 1/2 multicenter trial of DKN-01 as monotherapy or in combination with docetaxel for the treatment of metastatic castration-resistant prostate cancer (mCRPC). Prostate cancer and prostatic diseases (2024)
Hewitt Chang, Jaqueline Marquez Garcia, Brandon K Chen, Daniel M Kim, Michael L Cheng, Eric V Liu, Hai Yang, Li Zhang, Meenal Sinha, Alexander Cheung, Serena S Kwek, Eric D Chow, Mark Bridge, Rahul R Aggarwal, Terence W Friedlander, Eric J Small, Mark S Anderson, Lawrence Fong
Immune Modulation with RANKL Blockade through Denosumab Treatment in Patients with Cancer. Cancer immunology research 12 (4) (2024)
Edward B Maldonado, W Kimryn Rathmell, Geoffrey I Shapiro, Naoko Takebe, Jordi Rodon Ahnert, Devalingam Mahalingam, Nikolaos A Trikalinos, Arash Rezazadeh Kalebasty, Mamta Parikh, Scott A Boerner, Celene Balido, Gregor Krings, Timothy F Burns, Emily K Bergsland, Pamela N Munster, Alan Ashworth, Patricia M LoRusso, Rahul R Aggarwal
A Phase II Trial of the WEE1 Inhibitor Adavosertib in SETD2-Altered Advanced Solid Tumor Malignancies (NCI 10170). Cancer research communications 4 (7) (2024)
Hewitt Chang, Jaqueline Marquez Garcia, Brandon K Chen, Daniel M Kim, Michael L Cheng, Eric V Liu, Hai Yang, Li Zhang, Meenal Sinha, Alexander Cheung, Serena S Kwek, Eric D Chow, Mark Bridge, Rahul R Aggarwal, Terence W Friedlander, Eric J Small, Mark S Anderson, Lawrence Fong
Immune Modulation with RANKL Blockade through Denosumab Treatment in Patients with Cancer. Cancer immunology research 12 (4) (2024)
Mark C Markowski, Mary-Ellen Taplin, Rahul R Aggarwal, Laura A Sena, Hao Wang, Hanfei Qi, Aliya Lalji, Victoria Sinibaldi, Michael A Carducci, Channing J Paller, Catherine H Marshall, Mario A Eisenberger, David E Sanin, Srinivasan Yegnasubramanian, Carolina Gomes-Alexandre, Busra Ozbek, Tracy Jones, Angelo M DeMarzo, Samuel R Denmeade, Emmanuel S Antonarakis
Bipolar androgen therapy plus nivolumab for patients with metastatic castration-resistant prostate cancer: the COMBAT phase II trial. Nature communications 15 (1) (2024)
Rahul R Aggarwal, Glenn Heller, David W Hillman, Han Xiao, Joel Picus, Mary-Ellen Taplin, Tanya Barauskas Dorff, Leonard J Appleman, Douglas Weckstein, Akash Patnaik, Alan H Bryce, Daniel Shevrin, James L Mohler, Daniel Anderson, Arpit Rao, Scott T Tagawa, Alan Tan, Susan Halabi, Katharine E Dooley, Patrick O'Brien, Ronald C Chen, Charles J Ryan, Scott E Eggener, Michael J Morris, null null
PRESTO: A Phase III, Open-Label Study of Intensification of Androgen Blockade in Patients With High-Risk Biochemically Relapsed Castration-Sensitive Prostate Cancer (AFT-19). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (10) (2024)
Edward B Maldonado, W Kimryn Rathmell, Geoffrey I Shapiro, Naoko Takebe, Jordi Rodon Ahnert, Devalingam Mahalingam, Nikolaos A Trikalinos, Arash Rezazadeh Kalebasty, Mamta Parikh, Scott A Boerner, Celene Balido, Gregor Krings, Timothy F Burns, Emily K Bergsland, Pamela N Munster, Alan Ashworth, Patricia M LoRusso, Rahul R Aggarwal
A Phase II Trial of the WEE1 Inhibitor Adavosertib in SETD2-Altered Advanced Solid Tumor Malignancies (NCI 10170). Cancer research communications 4 (7) (2024)
Rahul R Aggarwal, Glenn Heller, David W Hillman, Han Xiao, Joel Picus, Mary-Ellen Taplin, Tanya Barauskas Dorff, Leonard J Appleman, Douglas Weckstein, Akash Patnaik, Alan H Bryce, Daniel Shevrin, James L Mohler, Daniel Anderson, Arpit Rao, Scott T Tagawa, Alan Tan, Susan Halabi, Katharine E Dooley, Patrick O'Brien, Ronald C Chen, Charles J Ryan, Scott E Eggener, Michael J Morris, null null
PRESTO: A Phase III, Open-Label Study of Intensification of Androgen Blockade in Patients With High-Risk Biochemically Relapsed Castration-Sensitive Prostate Cancer (AFT-19). Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Hewitt Chang, Jaqueline Marquez Garcia, Brandon K Chen, Daniel M Kim, Michael L Cheng, Eric V Liu, Hai Yang, Li Zhang, Meenal Sinha, Alexander Cheung, Serena S Kwek, Eric D Chow, Mark Bridge, Rahul R Aggarwal, Terence W Friedlander, Eric J Small, Mark S Anderson, Lawrence Fong
Immune Modulation with RANKL Blockade through Denosumab Treatment in Patients with Cancer. Cancer immunology research 12 (4) (2024)
Shuang G Zhao, Matthew Bootsma, Stanley Zhou, Raunak Shrestha, Thaidy Moreno-Rodriguez, Arian Lundberg, Chu Pan, Christopher Arlidge, James R Hawley, Adam Foye, Alana S Weinstein, Martin Sjostrom, Meng Zhang, Haolong Li, Lisa N Chesner, Nicholas R Rydzewski, Kyle T Helzer, Yue Shi, null null, Molly Lynch, Scott M Dehm, Joshua M Lang, Joshi J Alumkal, Housheng Hansen He, Alexander W Wyatt, Rahul R Aggarwal, Wilbert Zwart, Eric J Small, David A Quigley, Mathieu Lupien, Felix Y Feng
Integrated analyses highlight interactions between the three-dimensional genome and DNA, RNA and epigenomic alterations in metastatic prostate cancer. Nature genetics 56 (8) (2024)
Raunak Shrestha, Lisa N Chesner, Meng Zhang, Stanley Zhou, Adam Foye, Arian Lundberg, Alana S Weinstein, Martin Sjostrom, Xiaolin Zhu, Thaidy Moreno-Rodriguez, Haolong Li, Su C/Pcf West Coast Prostate Cancer Dream Team, Joshi J Alumkal, Rahul R Aggarwal, Eric J Small, Mathieu Lupien, David A Quigley, Felix Y Feng
An Atlas of Accessible Chromatin in Advanced Prostate Cancer Reveals the Epigenetic Evolution during Tumor Progression. Cancer research (2024)
Mark C Markowski, Mary-Ellen Taplin, Rahul R Aggarwal, Laura A Sena, Hao Wang, Hanfei Qi, Aliya Lalji, Victoria Sinibaldi, Michael A Carducci, Channing J Paller, Catherine H Marshall, Mario A Eisenberger, David E Sanin, Srinivasan Yegnasubramanian, Carolina Gomes-Alexandre, Busra Ozbek, Tracy Jones, Angelo M DeMarzo, Samuel R Denmeade, Emmanuel S Antonarakis
Bipolar androgen therapy plus nivolumab for patients with metastatic castration-resistant prostate cancer: the COMBAT phase II trial. Nature communications 15 (1) (2024)
Edward B Maldonado, W Kimryn Rathmell, Geoffrey I Shapiro, Naoko Takebe, Jordi Rodon Ahnert, Devalingam Mahalingam, Nikolaos A Trikalinos, Arash Rezazadeh Kalebasty, Mamta Parikh, Scott A Boerner, Celene Balido, Gregor Krings, Timothy F Burns, Emily K Bergsland, Pamela N Munster, Alan Ashworth, Patricia M LoRusso, Rahul R Aggarwal
A Phase II Trial of the WEE1 Inhibitor Adavosertib in SETD2-Altered Advanced Solid Tumor Malignancies (NCI 10170). Cancer research communications (2024)
Mark C Markowski, Mary-Ellen Taplin, Rahul R Aggarwal, Laura A Sena, Hao Wang, Hanfei Qi, Aliya Lalji, Victoria Sinibaldi, Michael A Carducci, Channing J Paller, Catherine H Marshall, Mario A Eisenberger, David E Sanin, Srinivasan Yegnasubramanian, Carolina Gomes-Alexandre, Busra Ozbek, Tracy Jones, Angelo M DeMarzo, Samuel R Denmeade, Emmanuel S Antonarakis
Bipolar androgen therapy plus nivolumab for patients with metastatic castration-resistant prostate cancer: the COMBAT phase II trial. Nature communications 15 (1) (2024)
Shuang G Zhao, Matthew Bootsma, Stanley Zhou, Raunak Shrestha, Thaidy Moreno-Rodriguez, Arian Lundberg, Chu Pan, Christopher Arlidge, James R Hawley, Adam Foye, Alana S Weinstein, Martin Sjostrom, Meng Zhang, Haolong Li, Lisa N Chesner, Nicholas R Rydzewski, Kyle T Helzer, Yue Shi, null null, Molly Lynch, Scott M Dehm, Joshua M Lang, Joshi J Alumkal, Housheng Hansen He, Alexander W Wyatt, Rahul R Aggarwal, Wilbert Zwart, Eric J Small, David A Quigley, Mathieu Lupien, Felix Y Feng
Integrated analyses highlight interactions between the three-dimensional genome and DNA, RNA and epigenomic alterations in metastatic prostate cancer. Nature genetics 56 (8) (2024)
Rahul R Aggarwal, Glenn Heller, David W Hillman, Han Xiao, Joel Picus, Mary-Ellen Taplin, Tanya Barauskas Dorff, Leonard J Appleman, Douglas Weckstein, Akash Patnaik, Alan H Bryce, Daniel Shevrin, James L Mohler, Daniel Anderson, Arpit Rao, Scott T Tagawa, Alan Tan, Susan Halabi, Katharine E Dooley, Patrick O'Brien, Ronald C Chen, Charles J Ryan, Scott E Eggener, Michael J Morris, null null
PRESTO: A Phase III, Open-Label Study of Intensification of Androgen Blockade in Patients With High-Risk Biochemically Relapsed Castration-Sensitive Prostate Cancer (AFT-19). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (10) (2024)
Shuang G Zhao, Matthew Bootsma, Stanley Zhou, Raunak Shrestha, Thaidy Moreno-Rodriguez, Arian Lundberg, Chu Pan, Christopher Arlidge, James R Hawley, Adam Foye, Alana S Weinstein, Martin Sjostrom, Meng Zhang, Haolong Li, Lisa N Chesner, Nicholas R Rydzewski, Kyle T Helzer, Yue Shi, null null, Molly Lynch, Scott M Dehm, Joshua M Lang, Joshi J Alumkal, Housheng Hansen He, Alexander W Wyatt, Rahul R Aggarwal, Wilbert Zwart, Eric J Small, David A Quigley, Mathieu Lupien, Felix Y Feng
Integrated analyses highlight interactions between the three-dimensional genome and DNA, RNA and epigenomic alterations in metastatic prostate cancer. Nature genetics 56 (8) (2024)
Nitya Raj, Jennifer A Chan, Stephanie J Wang, Rahul R Aggarwal, Susan Calabrese, April DeMore, Lawrence Fong, Jennifer Grabowsky, Thomas A Hope, Kanti Pallav Kolli, Claire K Mulvey, Pamela N Munster, Kimberly Perez, Sippy Punn, Diane Reidy-Lagunes, Sofia Von Fedak, Li Zhang, Emily K Bergsland
Pembrolizumab alone and pembrolizumab plus chemotherapy in previously treated, extrapulmonary poorly differentiated neuroendocrine carcinomas. British journal of cancer (2023)
Jimmy L Zhao, Emmanuel S Antonarakis, Heather H Cheng, Daniel J George, Rahul R Aggarwal, Elyn Riedel, Takayuki Sumiyoshi, Joseph D Schonhoft, Amanda Anderson, Ninghui Mao, Samuel Haywood, Brooke Decker, Tracy Curley, Wassim Abida, Felix Y Feng, Karen Knudsen, Brett Carver, Mario E Lacouture, Alexander W Wyatt, Dana E Rathkopf
Phase 1b study of enzalutamide plus CC-115, a dual mTORC1/2 and DNA-PK inhibitor, in men with metastatic castration-resistant prostate cancer (mCRPC). British journal of cancer (2023)
Daniel H Kwon, Kelly M Gordon, Barry Tong, Hala T Borno, Makenna Beigh, Delaire Fattah, Alexandra Schleicher, Rahul R Aggarwal, Amie M Blanco, Eric J Small, Mallika Dhawan
Implementation of a Telehealth Genetic Testing Station to Deliver Germline Testing for Men With Prostate Cancer. JCO oncology practice (2023)
Anil Parsram Bidkar, Sinan Wang, Kondapa Naidu Bobba, Emily Chan, Scott Bidlingmaier, Emily A Egusa, Robin Peter, Umama Ali, Niranjan Meher, Anju Wadhwa, Suchi Dhrona, Chandrashekhar Dasari, Denis R Beckford-Vera, Yang Su, Ryan Tang, Li Zhang, Jiang He, David M Wilson, Rahul R Aggarwal, Henry F VanBrocklin, Youngho Seo, Jonathan Chou, Bin Liu, Robert Richard Flavell
Treatment of prostate cancer with CD46 targeted 225Ac alpha particle radioimmunotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Arian Lundberg, Meng Zhang, Rahul R Aggarwal, Haolong Li, Li Zhang, Adam Foye, Martin Sjostrom, Jonathan Chou, Kevin Chang, Thaidy Moreno-Rodriguez, Raunak Shrestha, Avi Baskin, Xiaolin Zhu, Alana S Weinstein, Noah Younger, Joshi J Alumkal, Tomasz M Beer, Kim N Chi, Christopher P Evans, Martin E Gleave, Primo N Lara, Robert E Reiter, Matthew B Rettig, Owen N Witte, Alexander W Wyatt, Felix Y Feng, Eric J Small, David A Quigley
The genomic and epigenomic landscape of double-negative metastatic prostate cancer. Cancer research (2023)
Erica S Tsang, Rahul R Aggarwal, Mallika S Dhawan, Emily K Bergsland, Edwin A Alvarez, Susan Calabrese, Romain Pacaud, Jose Garcia, Delaire Fattah, Scott Thomas, Jennifer Grabowsky, Mark M Moasser, Pamela N Munster
A Phase IB Trial of the PI3K Inhibitor Alpelisib and Weekly Cisplatin in Patients with Solid Tumor Malignancies. Cancer research communications 2 (7) (2022)
Eric Feng, Nicholas R Rydzewski, Meng Zhang, Arian Lundberg, Matthew L Bootsma, Kyle T Helzer, Joshua M Lang, Rahul R Aggarwal, Eric J Small, David A Quigley, Martin Sjostrom, Shuang G Zhao
Intrinsic Molecular Subtypes of Metastatic Castration-Resistant Prostate Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Jonathan Chou, Emily A Egusa, Sinan Wang, Michelle L Badura, Fei Lee, Anil Parsram Bidkar, Jun Zhu, Tanushree Shenoy, Kai Trepka, Troy M Robinson, Veronica Steri, Jiaoti Huang, Yuzhuo Z Wang, Eric J Small, Emily Chan, Bradley A Stohr, Alan Ashworth, Brant Delafontaine, Sylvie Rottey, Keegan S Cooke, Nooshin Hashemi Sadraei, Brian Yu, Mark Salvati, Julie M Bailis, Felix Y Feng, Robert Richard Flavell, Rahul R Aggarwal
Immunotherapeutic targeting and PET imaging of DLL3 in small cell neuroendocrine prostate cancer. Cancer research (2022)
Rahul R Aggarwal, Alexander N Starodub, Brian D Koh, Guan Xing, Andrew J Armstrong, Michael A Carducci
Phase Ib Study of the BET Inhibitor GS-5829 as Monotherapy and Combined with Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (18) (2022)
Hala T Borno, Li Zhang, Hala T Borno, Celia Kaplan, Nynikka R Palmer, Alexander Bell, Brian Bakke, Amy Lin, Rahul R Aggarwal, Eric J Small
Mobile Clinical Trial Matching Technology in Medical Oncology Clinic: A Pilot Feasibility Study. JCO clinical cancer informatics 6 (2022)
Rahul R Aggarwal, Joshi J Alumkal, Russell Z Szmulewitz, Celestia S Higano, Alan H Bryce, Angela Lopez-Gitlitz, Sharon A McCarthy, Branko Miladinovic, Kelly McQuarrie, Shibu Thomas, Ke Zhang, Eric J Small
Randomized, Open-Label Phase 2 Study of Apalutamide plus Androgen Deprivation Therapy versus Apalutamide Monotherapy versus Androgen Deprivation Monotherapy in Patients with Biochemically Recurrent Prostate Cancer. Prostate cancer 2022 (2022)
Cameron Herberts, Matti Annala, Joonatan Sipola, Sarah W S Ng, Xinyi E Chen, Anssi Nurminen, Olga V Korhonen, Aslı D Munzur, Kevin Beja, Elena Schönlau, Cecily Q Bernales, Elie Ritch, Jack V W Bacon, Nathan A Lack, Matti Nykter, Rahul R Aggarwal, Eric J Small, Martin E Gleave, null null, David A Quigley, Felix Y Feng, Kim N Chi, Alexander W Wyatt
Deep whole-genome ctDNA chronology of treatment-resistant prostate cancer. Nature 608 (7921) (2022)
Thomas C Westbrook, Xiangnan Guan, Eva Rodansky, Diana Flores, Chia Jen Liu, Aaron M Udager, Radhika A Patel, Michael C Haffner, Ya-Mei Hu, Duanchen Sun, Tomasz M Beer, Adam Foye, Rahul R Aggarwal, David A Quigley, Jack F Youngren, Charles J Ryan, Martin Gleave, Yuzhuo Z Wang, Jiaoti Huang, Ilsa Coleman, Colm Morrissey, Peter S Nelson, Christopher P Evans, Primo Lara, Robert E Reiter, Owen Witte, Matthew Rettig, Christopher K Wong, Alana S Weinstein, Vladislav Uzunangelov, Joshua M Stuart, George V Thomas, Felix Y Feng, Eric J Small, Joel Anthony Yates, Zheng Xia, Joshi J Alumkal
Transcriptional profiling of matched patient biopsies clarifies molecular determinants of enzalutamide-induced lineage plasticity. Nature communications 13 (1) (2022)
Martin Sjostrom, Shuang G Zhao, Samuel Levy, Meng Zhang, Yuhong Ning, Raunak Shrestha, Arian Lundberg, Cameron Herberts, Adam Foye, Rahul R Aggarwal, Junjie T Hua, Haolong Li, Anna Bergamaschi, Corinne Maurice-Dror, Ashutosh Maheshwari, Sujun Chen, Sarah W S Ng, Michael Fraser, Jessica Petricca, Michael Fraser, Lisa Chesner, Marc D Perry, Thaidy Moreno-Rodriguez, William S Chen, Joshi J Alumkal, Jonathan Chou, Alicia K Morgans, Tomasz M Beer, George V Thomas, Martin Gleave, Paul Lloyd, Tierney Phillips, Erin McCarthy, Michael C Haffner, Amina Zoubeidi, Matti Annala, Robert E Reiter, Matthew B Rettig, Owen N Witte, Lawrence Fong, Rohit Bose, Franklin W Huang, Joshua M Lang, Anders Bjartell, Nupam P Mahajan, Primo N Lara, Christopher P Evans, Phuoc T Tran, Edwin M Posadas, Chuan He, Xiao-Long Cui, Jiaoti Huang, Wilbert Zwart, Luke A Gilbert, Christopher A Maher, Paul C Boutros, Kim N Chi, Alan Ashworth, Eric J Small, Housheng Hansen He, Alexander W Wyatt, David A Quigley, Felix Y Feng
The 5-Hydroxymethylcytosine Landscape of Prostate Cancer. Cancer research 82 (21) (2022)
Aaron S Mansfield, David S Hong, Christine L Hann, Anna F Farago, Himisha Beltran, Saiama N Waqar, Andrew E Hendifar, Lowell B Anthony, Matthew H Taylor, Alan H Bryce, Scott T Tagawa, Karl Lewis, Jiaxin Niu, Christine H Chung, James M Cleary, Michael Rossi, Carrianne Ludwig, Ricardo Valenzuela, Yan Luo, Rahul R Aggarwal
A phase I/II study of rovalpituzumab tesirine in delta-like 3-expressing advanced solid tumors. NPJ precision oncology 5 (1) (2021)
Wentao Chen, Kurt Yun Mou, Paige Solomon, Rahul R Aggarwal, Kevin K Leung, James A Wells
Large remodeling of the Myc-induced cell surface proteome in B cells and prostate cells creates new opportunities for immunotherapy. Proceedings of the National Academy of Sciences of the United States of America 118 (4) (2021)
Neha Singh, Varune R Ramnarine, Jin H Song, Ritu Pandey, Sathish K R Padi, Mannan Nouri, Virginie Olive, Maxim Kobelev, Koichi Okumura, David McCarthy, Michelle M Hanna, Piali Mukherjee, Belinda L Sun, Benjamin R Lee, J Brandon Parker, Debabrata Chakravarti, Noel A Warfel, Muhan Zhou, Jeremiah J Bearss, Ewan A Gibb, Mohammed Alshalalfa, R Jefferey Karnes, Eric J Small, Rahul R Aggarwal, Felix Y Feng, Yuzhuo Z Wang, Ralph Buttyan, Amina Zoubeidi, Mark A Rubin, Martin Gleave, Frank J Slack, Elai Davicioni, Himisha Beltran, Colin Collins, Andrew S Kraft
The long noncoding RNA H19 regulates tumor plasticity in neuroendocrine prostate cancer. Nature communications 12 (1) (2021)
Daniel H Kwon, Sneha Karthikeyan, Alison Chang, Hala T Borno, Vadim S Koshkin, Arpita Desai, Rohit Bose, Terence W Friedlander, Tammy Rodvelt, Patricia S Li, Eric J Small, Rahul R Aggarwal, Jeffrey Belkora
Mobile Audio Recording Technology to Promote Informed Decision Making in Advanced Prostate Cancer. JCO oncology practice 18 (5) (2021)
Fadi Taza, Albert E Holler, Wei Fu, Hao Wang, Nabil Adra, Costantine Albany, Ryan Ashkar, Heather H Cheng, Alexandra O Sokolova, Archana M Agarwal, Adam Kessel, Alan H Bryce, Nellie Nafissi, Pedro C Barata, A Oliver Sartor, Diogo Assed Bastos, Oren Smaletz, Jacob E Berchuck, Mary-Ellen Taplin, Rahul R Aggarwal, Cora N Sternberg, Panagiotis J Vlachostergios, Ajjai S Alva, Christopher T Su, Catherine Handy Marshall, Emmanuel S Antonarakis
Differential Activity of PARP Inhibitors in BRCA1- Versus BRCA2-Altered Metastatic Castration-Resistant Prostate Cancer. JCO precision oncology 5 (2021)